CMS changes mind on hospice drugs

Share this article:

The Centers for Medicaid & Medicare Services has revised guidance on authorization of hospice drugs for those under Medicare Advantage and Part D plans, according to a new memo.

The guidance memo, released July 18, says instead of having prior authorization for all hospice drugs, it will encourage PA requirements only on analgesics, antiemetics, laxatives and anti-anxiety drugs. These categories are common among terminally ill patients.

“This action by CMS will bring marked relief to hospice patients and their providers who have been dealing with the previous policy under which all drugs processed through Part D for hospice patients were subject to prior authorization,” said Andrea Devoti, National Association for Home Care & Hospice chairman of the board of directors.

The original requirement stemmed from concern that medications were being billed incorrectly to Part D plans. Hospices received a per-diem all-inclusive rate for a beneficiary. But hospice groups balked and said the new requirements would have forced terminally ill patients to fight between hospice providers and Part D plans, or give up on receiving medication.

Share this article:

More in News

Nursing home antipsychotic use has dipped nearly 19% under national effort, latest figures show

Nursing home antipsychotic use has dipped nearly 19% ...

The percent of long-stay nursing home residents receiving antipsychotic medication has decreased 18.8% under a nationwide initiative that started in 2012.

Jimmo succeeds in getting Medicare coverage, two years after landmark case ended

Glenda Jimmo has reached a settlement with the federal government and will finally receive Medicare coverage for claims that were denied in 2007, which led her to file a class-action lawsuit over the so-called "improvement standard."

Breier named new CEO at Kindred

Breier named new CEO at Kindred

Kindred Healthcare announced Thursday that it has chosen a new top executive to lead its push toward creating a mammoth national brand. Benjamin A. Breier, the company's current president and ...